Most of the mutations did not impact the ability of MX2 to inhibit infection as measured by challenging U87-MG CD4/CXCR4 cells with a GFP-encoding HIV-1-based vector (HIV-1/GFP) and enumerating the number of GFP-positive cells at 48 h. Here, MX2 is linked to infection.